Skip to main content
. Author manuscript; available in PMC: 2015 May 1.
Published in final edited form as: Mol Cancer Ther. 2014 Mar 14;13(5):1130–1141. doi: 10.1158/1535-7163.MCT-13-0880

Fig. 4. Effect of CRT0066101 on in vivo tumor growth.

Fig. 4

Athymic nude mice bearing HCT116 tumor xenografts were administered daily vehicle control (dextrose) or CRT0066101 at 40, 80, and 120 mg/kg orally for 3 weeks (5 mice per group). Tumor volume (A) and body weight (B) were measured 3 times per week. (C) Mouse and excised tumor images after treatment with CRT0066101. (D) Protein expression in xenografts was determined after 3 weeks of CRT0066101 treatment. Tumors were harvested 2 hours after the last dose.